Globally, rates of ESBL-producing Enterobacteriaceae are rising. We undertook a literature review, and present the temporal trends in bla CTX-M epidemiology, showing that bla CTX-M-15 and bla CTX-M-14 have displaced other genotypes in many parts of the world. Explanations for these changes can be attributed to: (i) horizontal gene transfer (HGT) of plasmids; (ii) successful Escherichia coli clones; (iii) ESBLs in food animals; (iv) the natural environment; and (v) human migration and access to basic sanitation. We also provide explanations for the changing epidemiology of bla CTX-M-2 and bla CTX-M-27 . Modifiable anthropogenic factors, such as poor access to basic sanitary facilities, encourage the spread of bla CTX-M and other antimicrobial resistance (AMR) genes, such as bla NDM , bla KPC and mcr-1. We provide further justification for novel preventative and interventional strategies to reduce transmission of these AMR genes.
Introduction
Extended-spectrum b-lactamases (ESBLs) hydrolyse the b-lactam ring of penicillins and third-generation cephalosporins (3GCs). They are mainly found in Enterobacteriaceae, which are part of the normal bowel flora, but can also be pathogenic, causing urinary tract infections and bloodstream infections. 1 The largest group of ESBLs are CTX-Ms, first identified in Germany, 2 France 3 and South America. 4 They have become globally disseminated, with bla CTX-M- 15 and bla CTX-M-14 being the predominant genotypes. CTX-M ESBLs have increased in prevalence since 2000, 5 and this presents huge challenges to healthcare, with restricted options to treat infections caused by CTX-M-producing bacteria. This has led to increased use of carbapenems, 6 leading to the emergence and spread of carbapenemase-producing Enterobacteriaceae. 7 Developing countries with low levels of sanitation provide opportunities for the transfer of antimicrobial resistance (AMR) genes in Enterobacteriaceae, including bla CTX-M , between humans, animals and the natural environment. 8, 9 Origin of CTX-M enzymes Humeniuk et al. 10 demonstrated that Kluyvera ascorbata, associated with the rhizosphere (the soil closely associated with plant roots), carries the chromosomal bla KLUA gene, which confers resistance to 3GCs. The chromosomal bla KLUA gene and its flanking regions are highly related to bla CTX-M enzymes and the flanking sequences on plasmids. 10 Each main cluster of CTX-M genotypes has a corresponding progenitor gene sharing homology with different Kluyvera spp., from which bla CTX-M genes originated. 11 Chromosomal bla KLUA from K. ascorbata is identical to bla CTX-M-2 , which is usually plasmid mediated, and therefore bla CTX-M-2 is likely to have originated from K. ascorbata. 12 Similarly, bla CTX-M-14 originates from a chromosomal gene in K. georgiana. 13 The CTX-M group 1 variant CTX-M-3 originated from K. ascorbata, 14 whereas CTX-M-37 is derived from K. cryocrescens. 15 It is likely that ISEcp1, frequently found upstream of bla CTX-M-14 16 and bla CTX-M- 15 17 in human isolates of Escherichia coli, played a key role in their mobilization. 10 The rise and global distribution of CTX-M variants ESBL prevalence increased over time in all WHO geographical regions, but these upward trends are statistically significant only for Europe (R 2 " 0.429, P " 0.04) ( Figure S1 , available as Supplementary data at JAC Online). A linear regression analysis showed a statistically significant rise in community ESBL rates over time for all regions (R 2 " 0.22, P , 0.005, plot not shown), supporting previous analyses. 5, 18 In particular, there is a strong upward trend in ESBL rates when this analysis is undertaken for developing countries only (R 2 " 0.814, P " 0.0004; Figure S2 ). The global picture of CTX-M variants is a complex one, but it is clear that bla CTX-M-15 has increased over time in most countries, and is dominant in most regions ( Figure 1 ). Exceptions are China, South-East Asia, South Korea, Japan and Spain, where group 9 variants (especially CTX-M-14) are dominant, and South America, where bla CTX-M-2 is still significant (Figure 1 ).
Our investigation of ESBL global epidemiology has focused on the temporal changes in bla CTX-M (Figure 1 ). We propose a number of interlinked factors as explanations for these global changes: (i) plasmids and horizontal gene transfer (HGT); (ii) successful E. coli clones; (iii) food animals; (iv) the natural environment; and (v) human migration and access to basic sanitation.
Methods

Search strategy and selection criteria
We searched the NCBI PubMed database without restrictions using the following search terms: 'CTX-M' and 'extended spectrum beta lactamase (ESBL)' plus 'Europe', 'North America', 'South America', 'Africa', 'Australasia', 'Asia' or 'South East Asia', as well as individual country names. These searches generated 2735 papers. Article inclusion criteria were as follows: (i) human Enterobacteriaceae isolates from community or hospital origin, from studies reporting infecting strains or from faecal carriage studies; (ii) isolates must have been identified using suitable screening media; (iii) collection dates and location of sampling; and (iv) bla CTX-M genotyping or multiplex PCR grouping data had to be provided. Articles were screened by reading abstracts. Using the inclusion criteria we identified 220 English articles for review, which were also checked for additional references not captured in the original searches. Figure 1 (a, b, c) CTX-M trends over three time periods for Europe (data include both hospital and community isolates). An asterisk indicates that, for these areas, only CTX-M grouping was done and these were not subdivided into genotypes. Note: many countries have no published data for certain time periods. Colour shades represent CTX-M groups: red, group 1; blue, group 9. (d, e, f) CTX-M trends over three time periods for the rest of the world (data include both hospital and community isolates). An asterisk indicates that, for these areas, only CTX-M grouping was done and these were not subdivided into genotypes. Note: many countries have no published data for certain time periods. South-East (SE) Asia includes Cambodia, Indonesia, Malaysia, The Philippines, Taiwan and Vietnam. Gulf States include Kuwait, Saudi Arabia and United Arab Emirates. Data for Australia and New Zealand are combined. GB ! , Guinea-Bissau. Colour shades represent CTX-M groups: red, group 1; green, group 2; orange, group 8/25; blue, group 9. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
Review
Statistics
Linear regression plots for the frequency of ESBL faecal carriage over time were plotted for each WHO region ( Figure S1 ) and for developing countries ( Figure S2 ).
Role of plasmid spread and HGT
The HGT of bla CTX-M genes on conjugative plasmids is fundamental to their evolution and global spread. 19 Several studies have shown that plasmids of the IncF family are the predominant group that carry bla CTX-M-15 , [20] [21] [22] [23] [24] whereas bla CTX-M-14 is carried on a variety of plasmid types, including on IncF, especially in the Far East, 25 and on IncK, in Western Europe. 26 Horizontal transfer of antimicrobial resistance plasmids by conjugation in Enterobacteriaceae occurs in the human gut, [27] [28] [29] animals 30 and the environment.
8,31
The IncF family plasmids have a narrow host range, being mainly restricted to Enterobacteriaceae, and contain a number of mechanisms, e.g. addiction systems and post-segregational killing machinery, favouring plasmid stability. 32 As a result, IncF plasmids are stably maintained in commensal E. coli within the gastrointestinal tract of humans and animals, without antimicrobial pressure, 33 perhaps explaining the global increase in community ESBL carriage ( Figure S1 ). Most bla CTX-M genes are carried by E. coli, but other members of the Enterobacteriaceae are associated with specific bla CTX-M genotypes. 33, 34 Identical plasmids which are found across genetically diverse strains have been termed 'epidemic plasmids', 33 and their dissemination helps to explain some of the global trends in bla CTX-M epidemiology. Examples of epidemic plasmids include pCT 26 and pHK01 35 (which both carry bla CTX-M-14 ), pC151a 36 (which carries bla CTX-M-15 ) and the closely related plasmids pEK516 and pEC_B24 (which also encode bla CTX-M-15 ). 32, 37 In South China it has been proposed that a discrete group of bla CTX-M-15 epidemic plasmids are circulating that share significant homology to pKF3-94-a Chinese reference plasmid isolated from Klebsiella pneumoniae-but are quite different from the pC151a-like plasmids described in Europe. 38 An epidemic IncI1 plasmid carrying bla CTX-M-1 has also been shown to be highly prevalent across food animal isolates and human isolates in the Netherlands, suggesting transmission of bla CTX-M-1 via the food chain. 39 Moreover, since the first description of bla CTX-M-1 from a clinical isolate in Germany in 1989, 2 bla CTX-M-1 has maintained a significant presence in several countries in Western Europe (Figure 1 ). Globally, CTX-M-1 is less common, and therefore the ongoing persistence of this genotype in Europe could well be due to the spread of epidemic plasmids. 39 One of the earliest reports of epidemic plasmid spread was the bla CTX-M-3 IncL/M plasmid, pCTX-M-3, which disseminated bla CTX-M-3 first in Poland, 40 and then throughout Europe. The genotype bla CTX-M-15 differs from bla CTX-M-3 by only one amino acid substitution, but the different genetic surroundings of these genes in Europe suggest that the evolution and subsequent spread of bla CTX-M-3 from Poland occurred independently of the subsequent rise of bla CTX-M-15 in the other regions. 41 Interestingly, Inc L/M plasmids carrying bla CTX-M-3 in China and Australia share significant homology, suggesting a common evolutionary origin. 42, 43 Perhaps the most worrying feature of bla CTX-M -bearing plasmids is their ability to capture additional resistance determinants, including carbapenemase genes. [44] [45] [46] For instance, p271A, which has close homology to the bla CTX-M-65 plasmid pJIE137, has a putative transposon bearing bla NDM-1 . 44 bla OXA-48 has been found on the same transposon as bla CTX-M- 15 46 and a hospital outbreak of K. pneumoniae producing OXA-48 and CTX-M-15 occurred in the Netherlands. 45 This situation, where globally successful bla CTX-M epidemic plasmids become effective vectors of carbapenemase genes, is extremely worrisome.
ISs, transposons and integrons have played a key role in the dissemination of bla CTX-M 47 via a diversity of genetic platforms.
11
ISEcp1 is the most common insertion element associated with bla CTX-M genes and has been described as being associated with all bla CTX-M genotypes. 11 ISEcp1 has two important characteristics: (i) it encodes a transposase, allowing mobilization of the bla CTX-M gene onto the particular plasmid; and (ii) it acts as a strong promoter for the expression of bla CTX-M . 48 The transposition element IS26 has also been important in the dissemination of group 1 and group 9 bla CTX-M variants. 11 Ensor et al.
49 investigated 130 ESBL-producing E. coli and K. pneumoniae isolates collected in 2003-05 from three Indian hospitals. Most of these isolates (73%) produced CTX-M-15 and, in 31% of these, IS26 was found within ISEcp1, upstream of bla CTX-M- 15 . 49 However, another group did not find IS26 in CTX-M-producing Enterobacteriaceae isolated in the late 1990s. 50 Therefore a specific event after 2000 led to capture of bla CTX-M-15 in India by IS26, which has been suggested as an event that has allowed stable maintenance of bla CTX-M in the gene pool thereafter. 49 Subsequently, IS26 has been found again in India 51 and worldwide. 11 More recently, Johnson et al. 52 investigated the association of IncF plasmids and IS26, and the clonal E. coli sub-group ST131 H30-Rx, using plasmid sequencing. Their results suggest that plasmids from H30-S and H30-R sub-groups were highly related to plasmids isolated from the later H30-Rx sub-group of ST131, except that only the H30-Rx group contained bla CTX-M- 15 . 52 In contrast to the early studies from India, 50, 53 it was suggested that IS26, which was found in high copy number across all isolates, was involved in mediating transposition of bla CTX-M-15 onto a common plasmid backbone. 52 Clearly, the selective pressure imparted by the use of 3GCs in humans and animals will increase the chance of the mobilization of bla CTX-M . Mobilization of MDR class I integrons, which are often associated with ISEcp1 and ISCR1 (particularly with group 2 and group 9 CTX-M 11 ), is particularly problematic because they often contain MDR cassettes. These include bla CTX-M , but also genes encoding resistance to clinically important antibiotics, such as fluoroquinolones, chloramphenicol, aminoglycosides and trimethoprim. 54 Therefore the overuse of any antibiotic with resistance in an MDR cassette provides evolutionary pressure for maintenance of all the MDR genes, and increased spread of the associated plasmid.
In addition to the clear roles of plasmid conjugation and transposition, or movement of bla CTX-M genes via integration or transposition, the role of bacteriophage-mediated transduction may be a key component of bla CTX-M transmission between bacteria and the environment. 55 Bacteriophages commonly carry antimicrobial resistance genes and have been found to be associated with bla CTX-M genotypes, which include bla CTX-M-10 , 56 bla CTX-M-27 57 and bla CTX-M- 15 . 58 In addition, AMR genes were found to be more abundant in phage DNA than in bacterial DNA. 59 Moreover, in mice treated with ciprofloxacin and amoxicillin, phage DNA was found Review JAC to be more highly enriched with antimicrobial resistance genes to these antibiotics compared with untreated mice. 60 There are clearly a number of different factors involved in the transfer of bla CTX-M ; this is likely to be a highly opportunistic process, influenced by the genetic composition of particular ESBL gene reservoirs and differential antibiotic selective pressures, thus leading to convergent/divergent evolution in different parts of the world.
The role of successful E. coli clones
In developed countries, E. coli causes more cases of bacteraemia than any other organism. [61] [62] [63] Worldwide surveys in 2008 led to the discovery of the international ESBL E. coli clone ST131, which belongs to phylogenetic group B2, serotype O25b:H4, and is now the major global extraintestinal pathogenic E. coli (ExPEC) strain. 64, 65 The clonal spread of virulent strains such as E. coli B2025:H4-ST131, which commonly carries bla CTX-M-15 , plays an important role in its global dissemination. 66, 67 The most widespread ESBL-producing ST131 sub-clone is H30-Rx, which commonly carries bla CTX-M-15 .
68
ST131 has been found mostly in human clinical E. coli isolates, but also in animals 69 and the environment. 31, 70 Successful in Western Europe and North America, 71 ST131 has been found only occasionally in India 72, 73 and China. [74] [75] [76] The most common bla CTX-M genotype in most regions of the world is bla CTX-M-15 ( Figure 1) , and a large proportion of CTX-M-producing E. coli are ST131.
Due to its relatively low prevalence in non-human isolates, ST131 probably originated from human sources. 71 The most common ST131 lineage, H30, has acquired fluoroquinolone resistance, followed by bla CTX-M-15 acquisition on a plasmid; both are associated with the sub-lineage H30-Rx. 68 Recent sequence analysis of global ST131 isolates suggests that H30-Rx originated in North America in around 1991. 77 The capture of fluoroquinolone resistance and bla CTX-M-15 by ST131 was a highly evolutionarily advantageous event given the high rates of use of fluoroquinolones and cephalosporins in the USA at that time. 77 One possibility is that the spread of bla CTX-M-15 and bla CTX-M-14 by human carriage from India and China, respectively, to North America, occurred. 78 This led to the capture of bla CTX-M-15 and bla CTX-M-14 by ST131 (onto preexisting plasmids in ST131 strains, via IS26-mediated transposition as discussed above), followed by clonal dissemination. Presumably the spread of ST131 E. coli out of North America was a later event. This theory is based on the assumption that, because bla CTX-M-14 and bla CTX-M-15 were first described in China and India, respectively, these countries were also the origin of these genotypes. This hypothesis is supported by phenotypic data from India and China in the late 1990s showing comparatively high rates of resistance to 3GCs, 79, 80 whereas in the USA around the same time ,1% of Gram negatives were 3GC resistant. 81 Importation of the successful H30-Rx sub-clone via human migration has probably led to the dominance of ST131 E. coli with bla CTX-M-15 in many regions of the world, such as Canada, 82, 83 Japan 84 and Israel. 85 In addition, non-Rx H30 strains of ST131 have also played a role in the clonal dissemination of bla CTX-M genes, such as in Japan, where H30-R ST131 isolates are associated with bla CTX-M-27 . 86 Moreover, non-H30 sub-clones such as H41 and H22
86 have also been associated with bla CTX-M genes in Japan 86 and Hong Kong. 87 Human migration is likely to have caused the spread of ST131 and has probably led to the displacement of existing genotypes by bla CTX-M-15 in other regions, especially South America and Western Europe (Figure 1) . ST131 is also known to carry bla CTX-M genotypes from all four main CTX-M groups, and notably is associated with bla CTX-M-14 (particularly in Canada, China, Japan and Spain). 66 
Food animals
The use of antimicrobials in food animals provides selective pressure for the propagation in animals of AMR bacteria that are often human pathogens. 88 Variants of bla CTX-M colonize the gut in farmed birds and mammals, 89, 90 as well as raw meat for human consumption. 91, 92 There is evidence for the transmission of ESBL-producing E. coli between animals and humans, 39, 93 and in the UK animal E. coli strains probably acquired the bla CTX-M plasmid from human strains. 94 Epidemic plasmid spread among animal and human E. coli strains has been found in the Netherlands, 39 China 35 and the UK.
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In the Netherlands, HGT between human and animal strains has a greater role than the clonal spread of E. coli strains between these niches, and plasmids in genetically diverse human and animal strains were almost identical. 39 The potential spread of bla CTX-M between animals and humans via the food chain, 39, 91 through animal handling 95 and from animals to the environment 96, 97 is made worse by the high prevalence of unregulated wet food markets in the developing world, for example in China. 98 Wet food markets sell a variety of foods, including meat/raw poultry without refrigeration or safe food handling practices. This microbial habitat, combined with heavy use of antibiotics in food animal production in China, 99 provides the perfect conditions for HGT from animal to human strains. This dynamic evolutionary situation explains why there is a tremendous diversity of bla CTX-M genotypes isolated from food animals in China ( Figure S3 ). The prevalence of bacteria producing CTX-M-55 in China has grown significantly in recent years in both animal 100 and human populations, 76 and it has been suggested that bla CTX-M-55 in human isolates arose from food animal sources. 101 Isolates of human and food animal origin share dominant bla CTX-M genotypes (Figures 1 and S3) , suggesting that there is clonal or horizontal exchange of bla CTX-M between these settings. Worldwide antibiotic use in food animals is projected to rise by 67% by 2030, and the role of food animals as a source of AMR genes is therefore likely to become more prominent. 102 
Natural environment
The natural environment is inextricably linked to human and animal reservoirs of ESBL producers. 5, 9 Since CTX-M enzymes originated in Kluyvera spp.-which normally inhabit the rhizosphereenvironmental sources probably play an important role in the dissemination of bla CTX-M . ESBLs have been found in sewage, 103 in rivers downstream of wastewater treatment facilities, 31 in urban freshwater, [104] [105] [106] in marine environments 107 and on farms. [108] [109] [110] Pollution of the environment with Enterobacteriaceae from human and animal waste is an issue in developing and developed Review countries. However, the poor standards of sanitation and the contamination of drinking water supplies in the developing world allow increased cycling of CTX-M-producing E. coli between humans and the environment. 7 This explains our finding of a significant upward trend in ESBL community carriage rates in developing countries ( Figure S2 ), notably in India, where ESBL carriage rates are amongst the highest in the world. 111 Moreover, the environmental-human exchange of AMR genes is highly relevant to the spread of other faecally carried genes, such as mcr-1 and bla NDM-1 . 112 The presence of resistance genes in an environment is closely related to anthropogenic activities. For example, the prevalence of class I integrons carrying resistance genes in sewage sludge, pig slurry and textile mill effluent is significantly higher than levels found in undisturbed soil. The common practice of using animal manure as fertilizer creates opportunities for species of Enterobacteriaceae to capture resistance genes on mobile genetic elements from soil bacteria. 9 More recently, a metagenomic approach was used to assess the AMR gene content across human, environmental and animal microbiomes in two developing regions in South America, and showed that mobile genetic elements played a significant role in the transfer of ESBLs between different resistomes. 8 Environmental contamination with fluoroquinolones is especially worrisome, as these drugs are known to persist in rivers and soil, and have the ability to select bacteria bearing class I integrons which carry resistance cassettes, including qnr genes and bla CTX-M genes. 9 In India, high levels of ciprofloxacin in the waste water effluents of pharmaceutical factories and in nearby sources of drinking water is a serious issue which is likely to be a contributory factor in the emergence and spread of bla CTX-M in human populations and in the environment. 113 
ESBL rates, migration and access to basic sanitation
There is increasing community prevalence of ESBL-producing Enterobacteriaceae worldwide ( Figure S1 ), especially CTX-M-15, which is reflected by much higher faecal carriage rates in Asia compared with Europe and North America. 5 Individuals with ethnic origins in the Middle East or South Asia (MESA) who reside in Europe have significantly higher carriage rates of CTX-M-15-producing E. coli compared with indigenous Europeans, which is likely to be due to the high frequency of travel by MESA people to these areas. 114 Prospective cohort studies have shown that travellers from Western countries visiting countries with a high prevalence of ESBLs become asymptomatic carriers: 75% of those travelling to Southern Asia acquired ESBL-producing bacteria. 115 Access to improved sanitation facilities, as defined by WHO/ UNICEF, is a key indicator of social and economic development, and is important in reducing the spread of diarrhoeal diseases. 116 We hypothesize that such access is also critical to controlling the spread of ESBLs. This has been identified by the O'Neill report as a key intervention in controlling resistance. Review JAC India, access to basic sanitation still falls below 40%. 116 We hypothesize that poor access to latrines in India, combined with high population density and increasing human migration, have made this region a key epicentre of ESBL evolution, and a source for the worldwide spread of bla CTX-M-15 .
Accounting for prominent global trends in CTX-M epidemiology: the fall of bla CTX-M-2 and the emergence of bla CTX-M-27
The distribution of CTX-M genotypes in particular geographical regions is not easily attributed to human migration. Given cultural links between Spain/Portugal and South America, it follows that CTX-M genotypes in these regions should be similar, due to frequent migration between these areas. However, whereas bla CTX-M-2 has been the main genotype in South America until the recent spread of bla CTX-M-15 , bla CTX-M-2 has never gained a foothold in Spain or Portugal. 41 One explanation for this phenomenon is that bla CTX-M-2 evolved in South America and was probably imported to Western Europe on multiple occasions, but lacked the successful evolutionary characteristics to compete with the dominant genotypes in Europe. Supporting this hypothesis, bla CTX-M-2 was the only genotype in South America in the early 1990s, 118 whereas during the same period in Spain, only group 1 CTX-M producers were described. 119 Outside South America, the only regions showing a predominance of bla CTX-M-2 , before 2004, were Japan 120 and Israel. 85 It is clear that bla CTX-M-2 is somehow evolutionarily less fit than its counterparts bla CTX-M-14 and bla CTX-M-15 , as these two genotypes have started to overtake bla CTX-M-2 in regions where it was previously the main CTX-M genotype (Figure 1 ).
There is increasing evidence to suggest that bla CTX-M-27 , a single-nucleotide variant of bla CTX-M-14 , has begun to out-compete other bla CTX-M genotypes, although CTX-M-15 and -14 are still the most common CTX-M enzymes globally (Figure 1 ). First identified from clinical E. coli in France, 121 bla CTX-M-27 is now found worldwide, recently gaining ground in Japan, China, South-East Asia, North America and Europe 74, 86, [122] [123] [124] [125] [126] [127] [128] (Figure 1 ). The cause of this rise is unclear: CTX-M-27 has a higher MIC of ceftazidime compared with CTX-M-14, so use of ceftazidime would theoretically select for bla CTX-M-27 .
129 E. coli clones producing CTX-M-27 may also be more transmissible in a nosocomial environment, when compared with CTX-M-15 producers. 130 As discussed above, there is genetic exchange of bla CTX-M by HGT and/or clonal exchange of CTX-M-producing E. coli between humans, animals and the environment. The presence of bla CTX-M-27 in food animal isolates from China in all three time periods (pre-2005; 2005-08; 2009-present) suggests a stable reservoir for bla CTX-M-27 in this ecological niche ( Figure S3 ). Indeed, bla CTX-M-27 identified from E. coli from food animals in a Chinese study represented 12% of bla CTX-M genotypes detected, 89 and bla CTX-M-27 also dominates ESBL-producing Salmonella serotypes in China. 131 In Vietnam as in China, where close proximity of animals and humans is common, bla CTX-M-27 is the most common bla CTX-M genotype, 123 which could be due to human transmission from animal sources.
Clonal spread of E. coli ST131 in humans has certainly played a role in the dissemination of bla CTX-M-27 in Japan, 84, 132 China, 74 France, 133 Portugal, 134 Germany 135 and the Czech Republic. 126 Moreover, E. coli ST131 isolates producing CTX-M-27 have been reported from companion animals in Japan, 136 from wild birds in the Czech Republic 137 and from freshwater in Switzerland. 70 However, ST131 CTX-M-27-producing isolates from South Korea and Japan did not belong to the H30-Rx sub-clone. 86, 138 Rather, Matsumura et al. 86 found that bla CTX-M-27 isolates were significantly associated with the H30-R sub-clone. They also suggested that although bla CTX-M-27 is a single-nucleotide variant of bla CTX-M-14 , bla CTX-M-27 is unlikely to have evolved by point mutation from bla CTX-M-14 in Japan, as the genetic surroundings and virulence profiles of bla CTX-M-27 versus bla CTX-M-14 are quite different. 86 This suggests that separate importations to Japan and/or separate bla CTX-M capture events to E. coli clonal lineages occurred for bla CTX-M-27 and bla CTX-M-14 .
The role of HGT in the spread of bla CTX-M-27 has poor coverage in the literature. However, interestingly, published data suggest that in animal strains bla CTX-M-27 is associated with a wide range of plasmid replicons in transconjugants, including N, FIB, FII, I1, HI2, A/C and P, 97, 131, 139 whereas in studies with human isolates bla CTX-M-27 has been found in E. coli ST131 strains associated with F1A, FIB and FII replicons only. 95, 138 Thus, one could speculate that bla CTX-M-27 has undergone transposition onto an IncF plasmid residing in E. coli ST131, similar to the IS26-mediated capture of bla CTX-M-15 described recently. 52 In addition, bacteriophage-mediated HGT is likely to play a role in bla CTX-M-27 dissemination, as recently found in Salmonella spp. from pork samples in China. 57 
Conclusions
Infections with CTX-M-producing Enterobacteriaceae are of huge clinical importance, as increasing rates of ESBL producers drive carbapenem prescribing, which in turn promotes the spread of potentially untreatable carbapenemase-producing Enterobacteriaceae. 140 Dealing with this situation requires constant monitoring of the global epidemiology of CTX-M genotypes, allowing early anticipation of emerging ESBL genes. Moreover, improving the global surveillance of AMR has been identified as a key intervention in addressing the rise of resistant bacteria. 117 This review has several limitations. Notably, in the early surveys of bla CTX-M , sample sizes were often small and several studies undertook only CTX-M-grouping PCR. Furthermore, many studies did not report on the clonal relatedness of the strains they included, leading to bias by outbreaks. There is publication bias: e.g. in China many studies describe CTX-M prevalence, whereas in Africa there are few studies. Therefore the limited data from under-resourced countries are likely to represent the tip of the iceberg in terms of percentage ESBL prevalence in these regions, leading to late detection of new genes. We used WHO/UNICEF data on access to improved sanitation facilities; such a facility is defined as 'one that hygienically separates human excreta from human contact'. 116 This includes pit latrines and flushing latrines, and it must be noted that the fate of this human waste is not recorded in these data and therefore the presence or effectiveness of onward sewage processing is not recorded. Therefore human exposure to human sewage (and therefore ESBL-producing bacteria) in many underdeveloped regions is likely to occur, even if access to improved sanitation facilities is high, and such exposures are likely even with high standards of sewage treatment. 31 
Review
We have shown that CTX-M community faecal carriage rates are rising ( Figures S1 and S2) , and this is more pronounced in developing countries, supporting previous studies. 18, 141 Therefore, there exists a vast human reservoir of bla CTX-M -producing strains, which provide a source of bacteria that often go on to cause antimicrobial-resistant infections. Equivalent ESBL reservoirs are present in the environment and in food-producing animals, which constantly exchange clones and mobile genetic elements with the human reservoir. Transfer of bla CTX-M thus occurs by the spread of clonal lineages, epidemic plasmid spread, or via the movement of smaller genetic elements by transposition or transduction. Although these processes are usually studied in isolation, they do not occur in isolation. Rather, we should apply the concept of the 'selfish gene':
142 each individual bla CTX-M gene is opportunistic, using every possible mechanism to propagate itself. Therefore the global success of bla CTX-M is due to a combination of all the mechanisms discussed above.
There is little doubt, however, that a combination of human factors has increased the propagation of bla CTX-M . Antibiotic overuse in humans and animals, increased global migration and population density, and contamination of the food chain and environment with human and animal waste promote AMR. 143 The evolution of highly successful lineages of CTX-M-producing bacteria is a critical factor. We have described the contribution of poor access to basic sanitation facilities in some countries as a risk factor for higher ESBL carriage. Poor sanitation access in these countries, combined with poor standards of animal husbandry, unregulated wet food markets, and antibiotic overuse in humans and animals is dangerous and provides opportunities for the evolution of novel AMR genes.
Where possible, attempts must be made to mitigate these risks through preventative strategies, such as improving access to latrines in developing countries, better antimicrobial stewardship in humans and animals, environmental controls and targeted evidence-based ESBL screening strategies. 117 This review will also support further research into novel interventions to reduce ESBL carriage, such as appropriate selective digestive decontamination or faecal microbiota transplantation. 144 Use of conjugation inhibitors 145 or plasmid curing 146 could be targeted at the gastrointestinal tract of humans or animals or the environmental resistome. Understanding the changing epidemiology and drivers of AMR also provides a baseline from which to measure the success of such interventions.
Bacteria carrying mcr-1 and/or carbapenemase genes are found in similar habitats to Enterobacteriaceae producing CTX-M, such as the human gut. Therefore, explanations for the trends observed in bla CTX-M epidemiology can be applied to these other faecally carried AMR genes.
This review has demonstrated a continued global rise in ESBL incidence. This has led to an inevitable rise in carbapenem use in humans, with an associated rise in resistance. We report dramatic regional shifts in the epidemiology of CTX-M-producing Enterobacteriaceae, but also remarkable stability in many regions. Both changes and stability in bla CTX-M genotypes in specific regions of the world seem to favour the highly successful bla CTX-M- 15 and bla CTX-M-14 genes. Understanding global temporal trends in these genotypes will help in the development of hypotheses as to why these changes occur, supporting strategies for reducing the spread of AMR in Gram-negative bacteria, averting excess mortality and preserving existing classes of antibiotics for future generations. edna 
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